Abstract:A bstract Among virtual screening methods that have been developed to facilitate the drug discovery process, chemogenomics presents the particularity to tackle the question of predicting ligands for proteins, at at scales both in the protein and chemical spaces. Therefore, in addition to to predict drug candidates for a given therapeutic protein target, like more classical ligand-based or receptor-based methods do, chemogenomics can also predict off-targets at the proteome level, and therefore, identify potential side-effects or drug repositioning opportunities. In this study, we study and compare machine-learning and deep learning approaches for chemogenomics, that are applicable to screen large sets of compounds against large sets of druggable proteins. State-of-the-art drug chemogenomics methods rely on expert-based chemical and protein descriptors or similarity measures. The recent development of deep learning approaches enabled to design algorithms that learn numerical abstract representations of molecular graphs and protein sequences in an end-to-end fashion, i.e., so that the learnt features optimise the objective function of the drug-target interaction prediction task. In this paper, we address drug-target interaction prediction at the druggable proteome-level, with what we define as the chemogenomic neuron network. This network consists of a feed-forward neuron network taking as input the combination of molecular and protein representations learnt by molecular graph and protein sequence encoders. We first propose a standard formulation of this chemogenomic neuron network. Then, we compare the performances of the standard chemogenomic network to reference deep learning or shallow (machine-learning without deep learning) methods. In particular, we show that such a representation learning approach is competitive with state-of-the-art chemogenomics with shallow methods, but not ultimately superior. We evaluate the most promising neuron network architectures and data augmentation techniques, such as multi-view and transfer learning, to improve the prediction performance of the chemogenomic network. Our results shed new insights on the design of chemogenomics approaches based on representation learning algorithms. Most importantly, we conclude from our observations that a promising research direction is to integrate heterogeneous sources of data such as various bioactivity datasets, or independently, multiple molecule and protein attribute views, instead of focusing on sophisticated, yet intuitively relevant, encoder’s neuron network architecture.

Quantum-to-Classical Neural Network Transfer Learning Applied to Drug Toxicity Prediction

Quantum to Classical Neural Network Transfer Learning Applied to Drug Toxicity Prediction

Hybrid Quantum Neural Network for Drug Response Prediction

Decoding toxicological signatures through quantum computational paradigm

Quantum Machine Learning Predicting ADME-Tox Properties in Drug Discovery

Hybrid quantum-classical convolutional neural networks to improve molecular protein binding affinity predictions

Binding affinity predictions with hybrid quantum-classical convolutional neural networks

A hybrid quantum-classical fusion neural network to improve protein-ligand binding affinity predictions for drug discovery

Novel Approach of Deep Learning in Toxicity Prediction

Quantum Machine Learning in Drug Discovery: Applications in Academia and Pharmaceutical Industries

Toxicity Prediction using Deep Learning

A deep learning based multi-model approach for predicting drug-like chemical compound's toxicity

A Review on the Recent Applications of Deep Learning in Predictive Drug Toxicological Studies.

Efficient Toxicity Prediction via Simple Features Using Shallow Neural Networks and Decision Trees

Near-Term Quantum Classification Algorithms Applied to Antimalarial Drug Discovery

Quantum Machine Learning for Drug Discovery

Evaluation of network architecture and data augmentation methods for deep learning in chemogenomics

Drug Toxicity Prediction by Machine Learning Approaches

TOP: Towards Better Toxicity Prediction by Deep Molecular Representation Learning

Deep-learning: investigating deep neural networks hyper-parameters and comparison of performance to shallow methods for modeling bioactivity data

Chemception: A Deep Neural Network with Minimal Chemistry Knowledge Matches the Performance of Expert-developed QSAR/QSPR Models